NCT07288788Recruiting
Assessment of Kidney Function in Patients With Epilepsy
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
This observational cross-sectional study aims to assess kidney function in pediatric patients with epilepsy attending Sohag University Hospital. The study evaluates renal biochemical markers, urinalysis, liver functions, abdominal ultrasonography, and the possible renal effects of long-term antiepileptic drug (AED) therapy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 21 Nov 2025
- Start date
- 28 Sept 2025
- Primary completion date
- 28 Sept 2025
- Lead sponsor
- Sohag University
- Diseases
- Epilepsy
- NCT number
- NCT07288788
What you commit to
- Study type: Observational
- Planned participants: 100
- From 28 Sept 2025 to the primary completion date, 28 Sept 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Children suffer from convulsions due to CNS infection
- Children with non idiobathic epilepsy
Age
- Age: children below 1month old\& children above 15 years old.
Who the study is looking for
- Age: children between 1month and 15years old.
- Both sexes.
- children who suffering from idiopathic epilepsy
Age in the registry: 1 month to 15 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag University Coordinator of this site? Confirm its status | Sohag | Egypt | Recruiting |
| Sohage Faculty of Medicine Coordinator of this site? Confirm its status | Sohag | Egypt | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.